Just curious if others have noticed what seems to be an increase in biotech companies raising cash this year? Don't have any hard numbers just a general observation from companies I follow (some I didn't think needed to do it anytime soon). Anyone who agrees would be curious on thoughts as to why?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.